Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

ClinicalTrials.gov ID: NCT03748641

Public ClinicalTrials.gov record NCT03748641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects With Metastatic Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP and placebo.

Study identification

NCT ID
NCT03748641
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
765 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2019 (Actual)
Primary completion
Oct 8, 2021 (Actual)
Completion
Dec 31, 2027 (Estimated)
Last update posted
Sep 25, 2026

2019 – 2027

United States locations

U.S. sites
47
U.S. states
29
U.S. cities
43
Facility City State ZIP Site status
Urology Centers Of Alabama Homewood Alabama 35209 —
Mayo Clinic Arizona Phoenix Arizona 85054 —
Urological Associates of Southern Arizona, P.C. Tucson Arizona 85741 —
Arkansas Urology Little Rock Arkansas 72211 —
Kaiser Permanente Riverside California 92505 —
San Bernardino Urological Associates San Bernardino California 92404 —
University of California San Francisco San Francisco California 94158 —
Sansum Clinic Pharm Santa Barbara California 93105 —
The Urology Center of Colorado Denver Colorado 80211 —
Colorado Clinical Research Lakewood Colorado 80228 —
VA Connecticut Healthcare West Haven Connecticut 06516 —
Bay Pines VA Healthcare System Bay Pines Florida 33744 —
Advanced Urology Institute Daytona Beach Florida 32114 —
University of Florida Health Jacksonville Jacksonville Florida 32209 —
Mayo Clinic - Division Of Hematology/oncology Jacksonville Florida 32224 —
Veterans Affairs Medical Ctr Hines Illinois 60141 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46825 —
First Urology Jeffersonville Indiana 47130 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Norton Healthcare Louisville Kentucky 40202 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Rcca Md, Llc Bethesda Maryland 20817 —
Chesapeake Urology Research Associates Towson Maryland 21204 —
Massachusetts General Boston Massachusetts 02114 —
Michigan Institute of Urology Troy Michigan 48084 —
Kansas City Veterans Affairs Medical Center Kansas City Missouri 64128 —
Adult Pediatric Urology & Urogynecology, P.C Omaha Nebraska 68114 —
Nebraska Cancer Specialists Omaha Nebraska 68130 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Delaware Valley Urology, LLC Mount Laurel New Jersey 08054 —
New York Oncology Hematology Albany New York 12208 —
Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg New York New York 10029 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Upstate Cancer Center Syracuse New York 13210 —
Helios Clinical Research, LLC Middleburg Heights Ohio 44130 —
Oregon Urology Institute Springfield Oregon 97477 —
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 —
Lancaster Urology Lancaster Pennsylvania 17604 —
VA Pittsburgh Pittsburgh Pennsylvania 15240 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Urology Associates Nashville Tennessee 37209 —
Houston Metro Urology Houston Texas 77027 —
University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Salem VA Medical Center Salem Virginia 80113 —
Urology of Virginia, PLCC Virginia Beach Virginia 23462 —
NorthWest Medical Specialties, PLLC Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 271 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03748641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03748641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →